Clinical Trial Update: The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing multiple-dose safety and efficacy of JS002 in patients with hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• JS002

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Hyperlipemia | Phase 3 | Status: COMPLETED